Cargando…

Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?

Harnessing dendritic cells (DC) to treat HIV infection is considered a key strategy to improve anti-HIV treatment and promote the discovery of functional or sterilizing cures. Although this strategy represents a promising approach, the results of currently published trials suggest that opportunities...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Laís Teodoro, Santillo, Bruna Tereso, de Almeida, Alexandre, Duarte, Alberto Jose da Silva, Oshiro, Telma Miyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305438/ https://www.ncbi.nlm.nih.gov/pubmed/30619346 http://dx.doi.org/10.3389/fimmu.2018.02993

Ejemplares similares

Differential inflammasome expression and IL-1β secretion in monocyte-derived dendritic cells differentiated with IL-4 or IFN-α
por: Pontillo, Alessandra, et al.
Publicado: (2013)

Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine
por: Oshiro, Telma Miyuki, et al.
Publicado: (2022)

Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil
por: Oliveira, Luanda Mara da Silva, et al.
Publicado: (2020)

What Happens to the Immune System after Vaccination or Recovery from COVID-19?
por: Tiyo, Bruna T., et al.
Publicado: (2021)

SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients
por: da Silva, Laís Teodoro, et al.
Publicado: (2021)

Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets
por: Romagnoli, Graziela Gorete, et al.
Publicado: (2015)

Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020)

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
por: de Almeida Baptista, Marcella Vassão, et al.
Publicado: (2022)

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias
por: Schürch, Christian M., et al.
Publicado: (2013)

Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
por: Gordon, John R., et al.
Publicado: (2014)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)

Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19
por: Ortega, Marina Mazzilli, et al.
Publicado: (2022)

In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy
por: Calmeiro, João, et al.
Publicado: (2021)

Monocyte-Derived Dendritic Cells Can Revert In Vitro Antigen-Specific Cellular Anergy in Active Human Paracoccidioidomycosis
por: Sato, Paula Keiko, et al.
Publicado: (2021)

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)

Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy
por: Pagni, Roberta Liberato, et al.
Publicado: (2022)

Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
por: Hargadon, Kristian M.
Publicado: (2017)

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
por: van Gulijk, Mandy, et al.
Publicado: (2018)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Editorial: Novel Platform for Antigen Delivery to Dendritic Cells for Immunotherapy
por: Plantinga, Maud, et al.
Publicado: (2022)

CpG Oligodeoxinucleotides and Flagellin Modulate the Immune Response to Antigens Targeted to CD8α(+) and CD8α(−) Conventional Dendritic Cell Subsets
por: Antonialli, Renan, et al.
Publicado: (2017)

Allergen-Specific Immunotherapy With Liposome Containing CpG-ODN in Murine Model of Asthma Relies on MyD88 Signaling in Dendritic Cells
por: Alberca-Custodio, Ricardo Wesley, et al.
Publicado: (2020)

Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets
por: Marques, Rui Ferreira, et al.
Publicado: (2023)

Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?
por: Butterfield, Lisa H.
Publicado: (2013)

Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
por: Patente, Thiago A., et al.
Publicado: (2019)

Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
por: Ni, Ling
Publicado: (2022)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
por: Gardam, Bryan, et al.
Publicado: (2023)

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
por: Matsumoto, Misako, et al.
Publicado: (2017)

The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
por: Peterson, Erin E., et al.
Publicado: (2021)

Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy
por: Zimmermann, Jennifer, et al.
Publicado: (2022)

TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
por: Skeate, Joseph G., et al.
Publicado: (2020)

The effect of organ-specific tumor microenvironments on response patterns to immunotherapy
por: Conway, Jordan W., et al.
Publicado: (2022)

Flagellin/NLRC4 Pathway Rescues NLRP3-Inflammasome Defect in Dendritic Cells From HIV-Infected Patients: Perspective for New Adjuvant in Immunocompromised Individuals
por: dos Reis, Edione Cristina, et al.
Publicado: (2019)

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
por: Botticelli, Andrea, et al.
Publicado: (2022)

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
por: Datta, Jashodeep, et al.
Publicado: (2015)

Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve?
por: Gozzi-Silva, Sarah Cristina, et al.
Publicado: (2021)

How Follicular Dendritic Cells Shape the B-Cell Antigenome
por: Kranich, Jan, et al.
Publicado: (2016)

NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis
por: Nico, Dirlei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fefc7bcj0go3td9n7s4lhorbq4